Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
1.190
-0.060 (-4.80%)
At close: Feb 11, 2026, 4:00 PM EST
1.200
+0.010 (0.84%)
After-hours: Feb 11, 2026, 7:57 PM EST
Codexis Employees
Codexis had 188 employees as of December 31, 2024. The number of employees increased by 14 or 8.05% compared to the previous year.
Employees
188
Change (1Y)
14
Growth (1Y)
8.05%
Revenue / Employee
$281,553
Profits / Employee
-$340,165
Market Cap
107.49M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 188 | 14 | 8.05% | 188 | 0 |
| Dec 31, 2023 | 174 | -74 | -29.84% | 174 | 0 |
| Dec 31, 2022 | 248 | -13 | -4.98% | 248 | 0 |
| Dec 31, 2021 | 261 | 80 | 44.20% | 261 | 0 |
| Dec 31, 2020 | 181 | 20 | 12.42% | 181 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 341 |
| Karyopharm Therapeutics | 279 |
| Inovio Pharmaceuticals | 134 |
| Fortress Biotech | 101 |
| Korro Bio | 87 |
| Cardiff Oncology | 33 |
| Cassava Sciences | 30 |
| Genelux | 24 |
CDXS News
- 1 day ago - Codexis Achieves ISO 9001:2015 Certification - GlobeNewsWire
- 5 weeks ago - Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics - PRNewsWire
- 3 months ago - Codexis Announces Signing of Lease for GMP Manufacturing Facility - GlobeNewsWire
- 3 months ago - Codexis, Inc. (CDXS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing - PRNewsWire
- 3 months ago - Codexis to Report Third Quarter 2025 Financial Results on November 6 - GlobeNewsWire
- 5 months ago - Codexis to Participate in Cantor Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Codexis, Inc. (CDXS) Q2 2025 Earnings Call Transcript - Seeking Alpha